Evidence-based strategies for site engagement to accelerate site activation and enrolment
Approximately 70% of clinical research sites report an increase in study execution burden[1], but when investigators have a superior experience with a sponsor they may enrol twice as many patients. [2]
This webinar will present evidence-based strategies to become partner of choice for high-performing sites by easing the site burden while making clinical trials more efficient.
This includes optimising site feasibility and activation, improving staff training and study compliance, and early engagement with sites to improve their understanding of the study protocol.
Global case studies will be shared, showing how these strategies allow for wider access to clinical trials and accelerated study start-up and enrolment.
Register for this webinar to learn how effective site engagement supports faster study activation and improved enrolment outcomes.
[1] Tufts Report, Volume 25, Number 1, Jan/Feb 2023
[2] The Clinical Trial Challenge: To Win Patients, Win Over Physicians | Bain & Company
Speakers
Ana Fernandez-Ramos, PhD, Lead Clinical Trial Liaison, ICON
Ana Fernandez-Ramos is the Lead Clinical Trial Liaison (CTL) for Europe, currently leading CTL activities for multiple projects at ICON, with over 7 years CRO experience. PhD trained with academic, industry and international site experience, Ana is highly skilled in providing clinical trial strategy for sponsors and cultivating site relationships, impacting trial efficiency and improving patient recruitment.
She’s experienced in national and international scientific conferences and workshops, delivering audience-specific scientific presentations to both scientific and non-scientific audiences.
Ana’s background is in novel pharmacological targets for solid transplants, but she has clinical expertise in vaccine trials, hematology, immunology (CD, UC, Lupus), chronic kidney disease, neurology (Alzheimer’s disease), solid cancers, and others.
Message Presenter
Manuel Rodriguez, MD, Principal Investigator, Florida Research Institute
Dr. Manuel Rodriguez serves as the Primary Investigator at the Florida Research Institute (FRI), where he leads a dedicated team in coordinating innovative clinical studies. With a commitment to advancing overall health, Dr. Rodriguez plays a pivotal role in highlighting FRI’s efforts to improve health outcomes through rigorous clinical trial research, having completed over 30 trials including fatty liver disease, cirrhosis, IBS, IBD, weight management, cancer screening, NSAID induced GI diseases, and device trials among others. His leadership and expertise contribute significantly to the institute’s mission of enhancing health and medical knowledge.
Dr. Rodriguez is board certified in Internal Medicine and Gastroenterology. He completed his residency and internship at University of Miami, Jackson Memorial Hospital and his fellowship at University of Texas, MD Anderson Cancer Center. Dr Rodriguez holds many professional memberships, including the American Society for Gastrointestinal Endoscopy, American Gastroenterology Association, American College of Gastroenterology.
Message PresenterWho Should Attend?
Professionals in the following areas within the pharmaceutical, biotech spaces:
- Clinical Development / Clinical Science
- Clinical Operations
- Clinical trial planning and optimization
- Data Management
- Decentralised Clinical Trial Operations
- Outcomes research
- Patient-Centric Innovation / Patient-centricity
- Procurement, Outsourcing
- Project Management
- Protocol Development
- Site feasibility / Site identification / Site intelligence
- Strategy and Innovation
What You Will Learn
Participants will learn the following during the presentation:
- Address and understand the increasing demands on clinical research sites
- Enact early site engagement and communication to relieve burden, increase protocol understanding and become a sponsor of choice
- Optimize site feasibility and activation for more efficient study-start-up with the right sites
- Improve site collaboration and training for increased compliance
Xtalks Partner
ICON
ICON plc is a world-leading clinical research organization powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 39,900 employees in 95 locations in 55 countries as of June 30, 2025. For further information about ICON, visit: www.iconplc.com.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account